EXPERIENCE WITH INTERMEDIATE-DOSE AND HIGH-DOSE CYTOSINE-ARABINOSIDE IN RELAPSED AND REFRACTORY ACUTE-LEUKEMIA

This publication has 9 references indexed in Scilit:

• The treatment of acute myelocytic leukemia in patients 30 years of age and younger
  American Journal of Hematology, 1982
• High Dose Cytosine Arabinoside in the Management of Refractory Acute Leukaemia
  Scandinavian Journal of Haematology, 1982
• Effects of high-dose cytarabine
  Clinical Pharmacology & Therapeutics, 1982
• A PILOT-STUDY OF HIGH-DOSE 1-BETA-D-ARABINOFURANOSYLCYTOSINE FOR ACUTE-LEUKEMIA AND REFRACTORY LYMPHOMA - CLINICAL-RESPONSE AND PHARMACOLOGY
  1982
• Selective Antimicrobial Modulation of Human Microbial Flora: Infection Prevention in Patients with Decreased Host Defense Mechanisms by Selective Elimination of Potentially Pathogenic Bacteria
  The Journal of Infectious Diseases, 1981
• Corneal Toxicity with Systemic Cytarabine
  American Journal of Ophthalmology, 1981
• Ara-C lung: Noncardiogenic pulmonary edema complicating cytosine arabinoside therapy of leukemia
  The American Journal of Medicine, 1981
• PREVENTION OF PLATELET REFRACTORINESS DUE TO HLA ANTIBODIES BY ADMINISTRATION OF LEUKOCYTE-POOR BLOOD COMPONENTS
  1981
• High dose cytosine arabinoside (HDARAC) in refractory acute leukemia
  Cancer, 1979